Cargando…

Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19

Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recog...

Descripción completa

Detalles Bibliográficos
Autores principales: Finance, Julie, Zieleskewicz, Laurent, Habert, Paul, Jacquier, Alexis, Parola, Philippe, Boussuges, Alain, Bregeon, Fabienne, Eldin, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160936/
https://www.ncbi.nlm.nih.gov/pubmed/34069557
http://dx.doi.org/10.3390/jcm10102196
_version_ 1783700395231543296
author Finance, Julie
Zieleskewicz, Laurent
Habert, Paul
Jacquier, Alexis
Parola, Philippe
Boussuges, Alain
Bregeon, Fabienne
Eldin, Carole
author_facet Finance, Julie
Zieleskewicz, Laurent
Habert, Paul
Jacquier, Alexis
Parola, Philippe
Boussuges, Alain
Bregeon, Fabienne
Eldin, Carole
author_sort Finance, Julie
collection PubMed
description Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. Method: To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. Results: Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. Conclusions: COVID-19 is currently accelerating the transition to low-dose and “no-dose” imaging techniques to explore infectious pneumonia and their long-term consequences.
format Online
Article
Text
id pubmed-8160936
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81609362021-05-29 Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19 Finance, Julie Zieleskewicz, Laurent Habert, Paul Jacquier, Alexis Parola, Philippe Boussuges, Alain Bregeon, Fabienne Eldin, Carole J Clin Med Review Background: The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. Method: To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. Results: Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. Conclusions: COVID-19 is currently accelerating the transition to low-dose and “no-dose” imaging techniques to explore infectious pneumonia and their long-term consequences. MDPI 2021-05-19 /pmc/articles/PMC8160936/ /pubmed/34069557 http://dx.doi.org/10.3390/jcm10102196 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Finance, Julie
Zieleskewicz, Laurent
Habert, Paul
Jacquier, Alexis
Parola, Philippe
Boussuges, Alain
Bregeon, Fabienne
Eldin, Carole
Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
title Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
title_full Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
title_fullStr Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
title_full_unstemmed Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
title_short Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19
title_sort low dose chest ct and lung ultrasound for the diagnosis and management of covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160936/
https://www.ncbi.nlm.nih.gov/pubmed/34069557
http://dx.doi.org/10.3390/jcm10102196
work_keys_str_mv AT financejulie lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT zieleskewiczlaurent lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT habertpaul lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT jacquieralexis lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT parolaphilippe lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT boussugesalain lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT bregeonfabienne lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19
AT eldincarole lowdosechestctandlungultrasoundforthediagnosisandmanagementofcovid19